|Articles|July 14, 2016
Merck US Job Cuts "Likely to Affect About 300 Workers"
July 14, 2016
Advertisement
As it builds news research hubs in Massachusetts and California, Merck's job cuts in New Jersey and Pennsylvania are likely to affect about 300 workers,
Although the company is not currently providing a breakdown of the changes or specific numbers of impacted employees, a Merck spokesperson told Fortune: “[W]e anticipate that less than 10 percent of discovery, pre-clinical and early development colleagues will be impacted".
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
The Agentic AI Revolution in Biopharma
3
340B Under Pressure: Inside Pharma's Push for Greater Clarity
4
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
5